Literature DB >> 826941

Oral taurine effects on inhibitory behavior: response transients to step-like schedule changes.

M A Persinger, G F Lafrenière, H Falter.   

Abstract

Rats habituated to DRL 6-s schedules that required response inhibition in order to obtain reward did not alter their total responses or efficiency ratios (response/reinforcement) when placed ad libitum (orally) on 0.9% taurine (1.1 +/- 0.4 g/kg/24-h) relative to controls. In three separate experiments, taurine-administerd rats did show significantly poorer adjustment profiles (higher response/reinforcement ratios) during the 15 min immediately following step-like increases in inhibition time demand to DRL 12 s. The effect was transient and was not signficant in subsequent sessions. Taurine rats had been habituated to a DRL schedule intended to induce "frustration" before and step-change did not differ from the taurine group maintained on the normal DRL schedule. No significant differences were noted between taurine and control groups, either before or after taurine administration or before or after the step-change in inhibition demand, with respect to defecation in the test chamber, daily fluid consumption, body weight or total responses. We concluded that oral taurine may inhibit learning during labile periods of adjustment following sudden changes of input demand but does not influence a well learned or established response pattern. These results imply taurine's role in the brain as a "stabilizer" against short-term input fluctuations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826941     DOI: 10.1007/BF00426824

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  Effects of taurine on psychomotor activity in the rat.

Authors:  S I Baskin; D L Hinkamp; W J Marquis; H A Tilson
Journal:  Neuropharmacology       Date:  1974-07       Impact factor: 5.250

2.  Effects of taurine on cortical acute epileptic foci.

Authors:  R Mutani; L Bergamini; R Fariello; M Delsedime
Journal:  Brain Res       Date:  1974-04-12       Impact factor: 3.252

3.  Taurine--a possible neurotransmitter?

Authors:  A N Davison; L K Kaczmarek
Journal:  Nature       Date:  1971-11-12       Impact factor: 49.962

4.  Passage of taurine into adult mammalian brain.

Authors:  N Urquhart; T L Perry; S Hansen; J Kennedy
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

5.  Taurine concentration in the neurohypophysis of different animal species.

Authors:  F Crabai; A Sitzia; G Pepeu
Journal:  J Neurochem       Date:  1974-11       Impact factor: 5.372

6.  Antagonism by taurine of cobalt induced epilepsy in cat and mouse.

Authors:  N M Van Gelder
Journal:  Brain Res       Date:  1972-11-27       Impact factor: 3.252

7.  Taurine distribution in cat brain.

Authors:  A Guidotti; G Badiani; G Pepeu
Journal:  J Neurochem       Date:  1972-02       Impact factor: 5.372

8.  Formation of taurine and isethionic acid in rat brain.

Authors:  E J Peck; J Awapara
Journal:  Biochim Biophys Acta       Date:  1967-08-29

9.  Weak inhibitory behavioral effects of postnatal! preweaning taurine injections in rats.

Authors:  M A Persinger; P M Valliant; H Falter
Journal:  Dev Psychobiol       Date:  1976-03       Impact factor: 3.038

  9 in total
  3 in total

1.  Impaired acquisition and retention of a passive avoidance response after chronic ingestion of taurine.

Authors:  P R Sanberg; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia.

Authors:  M Malcangio; A Bartolini; C Ghelardini; F Bennardini; P Malmberg-Aiello; F Franconi; A Giotti
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Dose-response effects of taurine on some open-field behaviors in the rat.

Authors:  P R Sanberg; K P Ossenkopp
Journal:  Psychopharmacology (Berl)       Date:  1977-07-18       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.